CN113136460A - H5N6 double-fluorescence quantitative RT-PCR detection kit - Google Patents

H5N6 double-fluorescence quantitative RT-PCR detection kit Download PDF

Info

Publication number
CN113136460A
CN113136460A CN202110524921.8A CN202110524921A CN113136460A CN 113136460 A CN113136460 A CN 113136460A CN 202110524921 A CN202110524921 A CN 202110524921A CN 113136460 A CN113136460 A CN 113136460A
Authority
CN
China
Prior art keywords
hsc
super
pcr
biog
mix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202110524921.8A
Other languages
Chinese (zh)
Inventor
袭细毛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Boshi Biotechnology Co ltd
Original Assignee
Guangzhou Boshi Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Boshi Biotechnology Co ltd filed Critical Guangzhou Boshi Biotechnology Co ltd
Priority to CN202110524921.8A priority Critical patent/CN113136460A/en
Publication of CN113136460A publication Critical patent/CN113136460A/en
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]

Abstract

The invention relates to a H5N6 dual fluorescence quantitative detection kit, which comprises: 2 × BIOGHSC S uper MultiProbe Mix,BIOGHSCSuper Enzyme Mix, H5-F, H5-R, N6-F, N6-R primer, H5-P, N6-P probe, RT-PCR Enhancer, RNase-free ddH2O, 50 XROX Reference Dye, T aq enzyme protection, 2 XBIOGHSCSuper Probe Master mix, positive control and negative control, wherein the positive control is a linear plasmid containing H5 and N6 gene fragments, and the negative control is PBS; the invention has the beneficial effect of providing the detection kit which has better specificity, stability and sensitivity and is used for detecting the H5N6 subtype avian influenza virus.

Description

H5N6 double-fluorescence quantitative RT-PCR detection kit
Technical Field
The invention belongs to the technical field of biology, and particularly relates to an H5N6 double-fluorescence quantitative RT-PCR detection kit.
Background
Influenza virus is a common respiratory infectious disease pathogen, is also a single-strand negative-strand RNA virus with an envelope, belongs to the family of orthomyxoviridae, and is classified into A, B, C, D types according to the antigenicity and gene evolution relationship of Nucleoprotein (NP) and Matrix protein (Matrix protein), wherein the influenza A virus has the greatest harm, has wide hosts, can infect human, poultry, horses, pigs, dogs, cats, mink, tiger, seal and whales, has strong infectivity, high propagation speed and easy variation, is difficult to prevent and control, often causes interpersonal pandemics and farm epidemics, and brings serious loss to human health and world economy. Avian Influenza Virus (AIV) belongs to influenza a virus, HA and NA are two main antigens on the surface of influenza virus, HA mainly functions to specifically recognize a receptor on the surface of a host cell, HA is a main antigen of an influenza virus stimulating an organism to produce an antibody, NA HAs sialidase activity, plays an important role in the release stage after the virus completes intracellular help, and cuts off the adhesion of progeny virus and the host cell to further infect other host cells. Influenza a viruses are classified into H1-H18 HA subtypes and N1-N11 NA subtypes according to differences in antigenicity of their surface antigens HA and NA, and currently, the predominant subtypes that prevail are H1N1, H2N 2, and H3N2, and recently, it HAs been found that influenza viruses of subtypes such as H5N1, H9N2, and H7N7 can also infect humans, and the predominant subtypes that circulate in birds are H5N1, H5N6, H7N7, H9N2, H6N6, H5N8, H10N8, and H5N 6.
In 1975, H5N6 subtype avian influenza virus was first isolated from green-head ducks in North America, in the past, H5N6 virus has the characteristic of low pathogenicity, is mainly popular in birds in America, Germany and Sweden, rarely produces symptoms, has little influence on human health and poultry farming industry, however, in recent years, in Asian countries, a series of H5N6 epidemic situations are developed, the fatality rate is extremely high, the characteristic of high pathogenicity is presented, severe loss is brought to poultry farming industry, symptoms such as fever and sore throat occur in 5 year old girls in 2 months in 2014, Hunan Changsha, and the like, are diagnosed to be positive in H5N6, which shows that the H5N6 subtype avian influenza virus can cross species to infect people, and various forms of gene recombination can cause brand new H5N6 to be generated, and in the process, part of H5N6 obtains receptor binding specificity adaptive to people, and enhances replication capacity, Virulence and drug resistance ultimately lead to the development of human infectious cases.
Fluorescent quantitative Real-time reverse transcription-polymerase chain reaction (RT-PCR) can distinguish subtypes of AIV. The double real-time fluorescent RT-PCR method aiming at the HA gene of H5 subtype and the NA gene of N6 subtype can improve the working efficiency, but at present, a primer pair and a probe which have high specificity, stability and sensitivity and are used for detecting the H5N6 subtype of the avian influenza virus are lacked.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provide a primer pair and a probe for detecting avian influenza virus H5N6 subtype, which have strong specificity, stability and sensitivity.
The specific primer sequences of the invention are shown in Table 1:
TABLE 1 primers and probes
Figure BDA0003065298930000021
The 5 'end of the H5 probe is labeled by FAM, and the 3' end is labeled by BHQ 1; the 5 'end of the N6 probe was labeled with HEX, and the 3' end was labeled with BHQ 1.
The kit of the present invention comprises: 2 × BIOGHSC Super MultiProbe Mix,BIOGHSCSuper Enzyme Mix, H5-F, H5-R, N6-F, N6-R primer, H5-P, N6-P probe, RT-PCR Enhancer, RNase-free ddH2O, 50 XROX Reference Dye, Taq enzyme protection solution, 2 XBIOGHSCSuper Probe Master mix, positive control and negative control.
The positive control is a linear plasmid containing HA and NA gene fragments, and the negative control is PBS.
The invention also relates to an avian influenza virus H5N6 subtype real-time fluorescence RT-PCR detection method, which is characterized by comprising the following steps:
1. extracting RNA of a sample to be detected;
2. preparing a fluorescent quantitative PCR reaction system, wherein the system is as follows:
2×BIOGHSC Super MultiProbe Mix 10μl,BIOGHSC0.5. mu.l of Super Enzyme Mix, 0.5. mu.l of RT-PCR Enhancer, 0.5. mu.l of H5, 0.5. mu.l of N6 upstream primer (10. mu.M), 0.5. mu.l of H5, N6 downstream primer (10. mu.M), 0.5. mu.l of probe (20. mu.M), RNase-free ddH2O3.5. mu.l, template H5N6 nucleic acid 4. mu.l;
the application method of the H5N6 dual fluorescent quantitative RT-PCR detection kit comprises the following reaction conditions of real-time fluorescent quantitative PCR: 40 cycles of 42 ℃ 20min, 95 ℃ 10min, (95 15s, 55 ℃ 35s, 72 ℃ 45 s). 10min at 72 ℃;
3. a linear plasmid containing an H5N6 gene fragment diluted by a 10-fold gradient is used as a standard substance to carry out real-time fluorescence quantitative PCR, and the PCR system is as follows:
BIOG HSC10 ul of Super Probe Master Mix, 0.5 ul of H5 and N6 upstream primer (10 uM), 0.5 ul of H5 and N6 downstream primer (10 uM), 2 ul of linear plasmid template, 0.5 ul of Probe, 0.4 ul of 50 XROX Reference Dye, 0.2 ul of Taq enzyme protection solution, and ddH2And (3) carrying out reaction for 40 cycles of O5.9 mul, wherein the reaction program is 95 ℃ for 10min, (95 ℃ for 15s, 55 ℃ for 35s and 72 ℃ for 45s), the reaction program is 72 ℃ for 10min, a standard curve is established by taking the Log value of the copy number of the plasmid as the abscissa and the Ct value as the ordinate, and then the real-time fluorescence quantitative PCR detection result of the sample to be detected is compared with the standard curve to obtain the detection result.
The invention further analyzes the specificity, sensitivity and stability of the established H5N6 dual-fluorescence quantitative RT-PCR detection kit, wherein:
and (3) specific detection: the kit is used for carrying out fluorescence quantitative RT-PCR detection by taking RNA (ribonucleic acid) of H2N3, H5N5, H5N6, H5N1, H7N2, H8N4, H10N3, H1N7, H11N9, H7N9, H3N2, H6N6, H9N6 and H9N2 as templates.
And (3) sensitivity detection: constructing pcDNA3.1-H5-N6 plasmid containing H5 gene fragment and N6 gene fragment, quantifying the plasmid by using a micro nucleic acid quantifier NanoDrop, and taking 10 and 102、103、104、105、106、107、108And (3) taking the copied/mul recombinant plasmid as a standard template, respectively adding the standard template into the system for amplification, and constructing a standard curve according to the Ct value and the Log value of the template concentration for calculating the minimum detection limit of the detection system.
And (3) stability detection: in the same experiment, in the same PCR plate, according to 10-fold gradient dilution, three dilution gradients are set, double real-time fluorescence RT-PCR detection is carried out on the H5N6 avian influenza virus positive nucleic acid, each sample is carried out with three repetitions, in addition, the three repetitions are carried out on different PCR plates, and the coefficient of variation of the Ct value obtained by the three repeated reactions of each dilution sample is calculated.
The invention has the beneficial effects that:
provides a detection kit with better specificity, stability and sensitivity for detecting the H5N6 subtype avian influenza virus.
Drawings
FIG. 1 shows the amplification results of the H5N6 gene in FAM and HEX channels
FIG. 2 amplification results of H5N5 and H5N1 genes in FAM channel
FIG. 3 shows the results of the HEX channel amplification of H6N6 and H9N6 genes
FIG. 4 Standard Curve
Detailed Description
The present invention will be described in further detail with reference to the following examples, which are provided only for illustrating the present invention and are not intended to limit the scope of the present invention.
Example 1
1. Primary reagent
H2N3, H5N5, H5N6, H5N1, H7N2, H8N4, H10N3 RNA were given by Hongkong university, H1N7, H11N9 RNA were given by Pennsylvania university, H7N9, H3N2, H6N6, H9N6, H9N2RNA were given by Guangxi autonomous region disease control center, QIAamp Viral RNA extraction kit was purchased from QIAGEN, BIOG, GermanyHSCSuper MuhiProbe One Step Kit and BIOGHSCThe Super Probe Kit is purchased from Bai generation organisms in Changzhou, the gel recovery Kit is purchased from Axygen company, and the pcDNA3.1 vector is purchased from Shanghai Solebao Biotech Co., Ltd;
2. main instrument equipment
ABI7300 fast real-time fluorescent PCR instrument was purchased from Thermo fisher, USA, AB104-N electronic analytical balance was purchased from Mettler-Torledo Shanghai, Inc., Sigma 3K-15 high-speed refrigerated centrifuge was purchased from Sigma, Germany, and MilliQ Integrated ultrapure water instrument was purchased from Millipore, USA;
searching HA gene sequences (MG220416.1, SEQ ID NO.7) and NA gene sequences (MK779125.1 and SEQ ID NO.8) of the H5N6 avian influenza virus strain from NCBI, and designing specific primers and TaqMan probe sequences aiming at conserved regions by using Primer Epress 3.0.1 software, wherein the Primer sequences are shown in Table 1, H5-P fluorescence emission groups are FAM, N6-P fluorescence emission groups are HEX, and quenching groups are BHQ-1;
3. preparing a fluorescent RT-PCR detection system according to the specification, wherein the specific preparation system is shown in table 2, and the RT-PCR reaction program is shown in table 3;
TABLE 2 RT-PCR reaction System
Composition (I) Volume (μ l)
2×BIOGHSC Super MultiProbe Mix 10
BIOGHSC Super Enzyme Mix 0.5
RT-PCR Enhancer 0.5
H5, N6 upstream primer (10. mu.M) 0.5
H5, N6 downstream primer (10. mu.M) 0.5
Probe (20 μ M) 0.5
Rnase-free ddH2O 3.5
Template H5N6 nucleic acid 4
TABLE 3 RT-PCR reaction procedure
Temperature of Time Number of cycles
42℃ 20min -
95℃ 10min -
95℃ 15s 40
55 35s 40
72 45s 40
72℃ 10min -
The result judgment standard is as follows: the Ct value is less than or equal to 33, and the test piece is judged to be positive; the Ct value is more than or equal to 35, and the judgment is negative; ct values were suspect between 33-35 and were repeated once, and positive if Ct values were still between 33-35, three replicates per sample were set.
Example 2 specificity verification
The experimental procedure was the same as in example 1, and fluorescence quantitative RT-PCR amplification was carried out using the kit, using H2N3, H5N5, H5N6, H5N1, H7N2, H8N4, H10N3, H1N7, H11N9, H7N9, H3N2, H6N6, H9N6, and H9N2 RNAs as templates, respectively.
As can be seen from FIG. 1, only H5N6 avian influenza virus nucleic acid shows corresponding specific fluorescence amplification curves in both FAM detection channel and HEX detection channel, as can be seen from FIG. 2, H5N5 and H5N1 contain H5 gene, thus showing amplification curve in FAM detection channel, while HEX detection channel shows no amplification curve, as can be seen from FIG. 3, H6N6 and H9N6 contain N6 gene, thus showing that amplification curve in HEX detection channel, FAM detection channel shows no amplification curve, and both fluorescence channels of other influenza virus show no amplification curve, thus indicating that the method has strong specificity.
Example 3 sensitivity verification
Construction and identification of HA gene and NA gene positive plasmids of H5N6 avian influenza virus, common PCR amplification is carried out by using HA gene and NA gene specific primers aiming at H5N6 avian influenza virus, HA gene primer sequences are shown as SEQ ID NO.9 and SEQ ID NO.10, NA gene primer sequences are shown as SEQ ID NO.11 and SEQ ID NO.12, the amplification range comprises a fluorescent quantitative RT-PCR amplification area, after the HA gene and NA gene PCR reaction is finished, mixing, adding 20 mul of Cloning Enhancer into a PCR system, incubating for 15min at 37 ℃, incubating for 15min at 80 ℃, adopting AflII and BamH I to carry out enzyme digestion on pcDNA3.1 plasmid, after 0.75% agarose gel electrophoresis, recovering enzyme digestion products, dissolving In sterilized double distilled water, mixing the PCR products with purified linear vectors uniformly, adding In-Fusion enzyme, reacting for 15min at 50 ℃, converting E.coli positive DH5 alpha, picking up and Cloning, sequencing by a biological company, carrying out amplification culture on correctly identified plasmids, extracting the plasmids, carrying out enzyme digestion on the recombinant plasmids by using BssHII to obtain linearized plasmid DNA serving as a positive plasmid for constructing a standard curve and named pcDNA3.1-H5-N6.
pcDNA3.1-H5-N6 positiveThe plasmid was quantified by NanoDrop using a nucleic acid minimeter, and 10 were taken2、103、104、105、106、107、108Taking the copied/microliter recombinant plasmid as a standard template to perform PCR amplification, wherein the amplification system is as follows:
BIOG HSC10 ul of Super Probe Master Mix, 0.5 ul of H5 and N6 upstream primer (10 uM), 0.5 ul of H5 and N6 downstream primer (10 uM), 2 ul of linear plasmid template, 0.5 ul of Probe, 0.4 ul of 50 XROX Reference Dye, 0.2 ul of Taq enzyme protection solution, and ddH2And (3) O5.9 mul, wherein the reaction program is 95 ℃ for 10min, (95 ℃ for 15s, 55 ℃ for 35s, and 72 ℃ for 45s) for 40 cycles, and the reaction program is 72 ℃ for 10min, and a standard curve is constructed according to the Ct value and the Log value of the template concentration and is used for calculating the minimum detection limit of the detection system.
Experimental results show that the cycle threshold (Ct value) of a standard curve constructed by pcDNA3.1-H5-N6 positive plasmids has a good linear relation with a Log value of template concentration, the correlation coefficient is 0.997, and the sensitivity is 68 copies/mul.
Example 4 stability verification
In the same experiment, in the same PCR plate, according to 10-fold gradient dilution, three dilution gradients are set, double real-time fluorescence RT-PCR detection is carried out on the H5N6 avian influenza virus positive nucleic acid, the detection method is as in example 1, each sample is repeated three times (see table 3), and in addition, the samples are repeated three times on different PCR plates, and the variation coefficient of the Ct value obtained by three repeated reactions of each dilution sample is calculated (see table 4).
The test results show that the coefficient of variation of the same PCR plate is between 0.19 and 0.32 percent, and the coefficient of variation of different PCR plates is between 0.37 and 0.44 percent, which shows that the double RT-PCR detection method has small error and good repeatability, and can stably and reliably detect the H5N6 avian influenza virus.
TABLE 3 duplicate results of the H5N6 avian influenza Virus Dual fluorescent RT-PCR detection method in batches
Figure BDA0003065298930000071
TABLE 4 batch-to-batch repeat results of the H5N6 avian influenza Virus Dual fluorescent RT-PCR detection method
Figure BDA0003065298930000072
Sequence listing
<110> Guangzhou Bojii Biotechnology Ltd
<120> H5N6 double-fluorescence quantitative RT-PCR detection kit
<160> 12
<170> SIPOSequenceListing 1.0
<210> 1
<211> 24
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
gggacatcaa cattaaacca gaga 24
<210> 2
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
tgcccgttta cttgggatct 20
<210> 3
<211> 14
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
tggtgccaaa aata 14
<210> 4
<211> 21
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
tgcgaatgga accatacatg a 21
<210> 5
<211> 25
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 5
tgacccattt cccaacttat aagag 25
<210> 6
<211> 14
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
aggagcccat ttcg 14
<210> 7
<211> 1751
<212> DNA
<213> Influenza A virus
<400> 7
ggttcaatct gtcaaaatgg agaaaatagt gcttcttctt gcagtgatta gccttgttaa 60
aagtgatcag atttgcattg gttaccatgc aaacaactcg acagagcagg ttgacacgat 120
aatggaaaaa aacgtcactg ttacacatgc ccaagacata ctggaaaaga cacacaacgg 180
gaggctctgc gatctgaatg gagtgaaacc tctgatttta aaggattgta gtgtagctgg 240
atggcttctt ggaaacccaa tgtgcgacga gttcatcaga gtgccggaat ggtcctacat 300
agtggaaagg gctaacccaa ccaatgacct ctgttaccca gggaatctca atgattacga 360
agaactgaaa cacttattga gcagaataaa tcattttgag aagactctga tcatccccaa 420
gagttcttgg cccaatcatg aaacatcatt gggggtgagc gcagcttgtc cataccaggg 480
aatgccctct tttttcagaa atgtggtatg gcttaccaag aagaacgatg catacccaac 540
aataaagatg agctacaata ataccaatag ggaagatctt ttgatactgt gggggattca 600
tcatcccaac aatgaagcag agcaaaaaag tatctataaa aatccaacca cctatgtttc 660
cgttgggaca tcaacattaa accagagatt ggtgccaaaa atagctacta gatcccaagt 720
aaacgggcaa cgtggaagaa tggatttctt ctggacaatt ttaaaaccga atgatgcaat 780
ccatttcgag agtaatggaa attttattgc tccagaatat gcatacaaaa ttgtcaagaa 840
aggggactca acaattatga aaagtgaaat ggaatacggc tactgcaaca ccaaatgtca 900
aactccaata ggggcgataa actctagtat gccattccac aatatacacc ctctcactat 960
cggggagtgc cccaaatacg tgaaatcaaa caaattagtc cttgcgactg ggctcagaaa 1020
tagtcctcta agagaaagaa gaagaaaaag agggctattt ggagctatag cagggtttat 1080
agagggagga tggcaaggaa tggtagatgg ttggtatggg tatcaccata gcaatgaaca 1140
ggggagtggg tacgctgcag acagagaatc cacccaaaag gcaatagatg gagttaccaa 1200
taaggtcaac tcgatcattg acaaaatgaa cactcaattt gaggccgttg gaagggaatt 1260
caataactta gaacggagaa tagaaaattt aaataagaaa atggaagacg gattcctaga 1320
tgtctggact tataatgctg aacttttagt tctcatggaa aatgagagaa cgctagattt 1380
ccatgactca aatgtcaaga acctttatga caaagtccga ctacagctta gggataatgc 1440
aaaggagctg ggtaacggtt gtttcgagtt ttatcacaaa tgtgataatg aatgtatgga 1500
aagtgtaaga aatgggacgt acgactaccc ccaatattca gaagaagcaa gattaaaaag 1560
ggaagaaata agcggagtga aactggaatc aataggaact taccaaatac tgtcaattta 1620
ttcaacagtg gcgagttccc taacactggc aatcatcttg gctggtctat ctttatggat 1680
gtgctccaat gggtcgttac aatgcagaat ttgcatttaa atttgtgagc tcaaattgta 1740
attaaaaaca c 1751
<210> 8
<211> 1432
<212> DNA
<213> Influenza A virus
<400> 8
agcaaaagca gggtgaaaat gaatccaaat caaaagataa catgcatttc agcaacagga 60
gtaacactat cagtagtaag cctgctaata ggaatcacca atttgggcct aaatattgga 120
ctacactaca aagtgagtga ttcaacaact ataaacattc caaacatgaa tgagactaac 180
ccaacaacaa caaacatcac taacattata atgaataaga acgaagaaag aacatttctt 240
aaattgacca agccactatg tgaagtcaac tcatggtaca ttctatcgaa agacaatgcg 300
ataagaatag gtgaggatgc tcatatactg gtcacaaggg aaccttacct gtcctgtgat 360
ccacaaggct gcagaatgtt tgctctgagt cagggcacaa cactcagagg gcaacatgcg 420
aatggaacca tacatgatag gagcccattt cgagctctta taagttggga aatgggtcag 480
gcacccagtc catacaatac tagggtcgaa tgcataggat ggtcaagcac gtcatgccat 540
gatggcatat caaggatgtc aatatgcata tcaggaccga ataacaatgc atcggcagtg 600
gtgtggtacc gggggagacc aataacagaa atcccatcat gggcagggaa cattcttagg 660
actcaagaat cagaatgtgt gtgccataaa ggaatctgcc cagtggtcat gacagatggt 720
ccagcaaaca acaaggcagc aactaagata atctacttca aagagggaaa gatacaaaaa 780
actgaagaat tgcaagggaa cgctcaacac atcgaagaat gttcatgcta cggagcagca 840
gggatgatca aatgtgtatg cagagacaac tggaaggggg caaatagacc agtaatcact 900
ataaatcccg aaatgatgac ccacacaagc aaatacttgt gttcgaaaat cttaaccgac 960
acaagtcgcc ctaatgatcc caccaatggg aactgtgacg caccaataaa aggagggagc 1020
ccagacccag gggtaaaagg gtttgcattc ctagatgggg agaattcatg gcttgggagg 1080
acaattagca aagactccag atcaggttac gaaatgttga aggtcccaaa tgcagaaatc 1140
gacactcaat cagggccaat ctcataccag ctgattgtca acaaccaaaa ttggtcaggg 1200
tactcagggg cattcataga ctactgggca aacaaggagt gcttcaatcc ttgtttttat 1260
gtggagctaa tcagggggag acccaaagag agtggtgtac tgtggacttc caatagcatg 1320
gtagctctct gtggatccag ggagcgattg ggatcatggt cctggcatga tggtgcagaa 1380
atcatctact ttaagtagaa gtgatttaag aaaaaacacc cttgtttcta ct 1432
<210> 9
<211> 44
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 9
gatcagcggt ttaaacttaa gcaacaatga agcagagcaa aaaa 44
<210> 10
<211> 37
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 10
aggacaggta aggtgcagta gccgtattcc atttcac 37
<210> 11
<211> 30
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 11
tactgcacct tacctgtcct gtgatccaca 30
<210> 12
<211> 45
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 12
ccacactgga ctagtggatc cgcattgtta ttcggtcctg atatg 45

Claims (2)

1. A H5N6 double fluorescence quantitative RT-PCR detection kit is characterized by comprising: 2 × BIOGHSC Super MultiProbe Mix,BIOGHSCSuper Enzyme Mix, H5-F, H5-R, N6-F, N6-R primer, H5-P, N6-P probe, RT-PCR Enhancer, RNase-free ddH2O, 50 XROX reference Dye, Taq enzyme protection solution, 2 XBIOGHSCSuper Probe Master mix, PositiveA control and a negative control, wherein the positive control is a linear plasmid containing H5 and N6 gene fragments, the negative control is PBS, and the H5-F sequence is as follows: GGGACATCAACATTAAACCAGAGA, the sequence of H5-R is: TGCCCGTTTACTTGGGATCT, the sequence of H5-P is: TGGTGCCAAAAATA, the sequence of N6-F is: TGCGAATGGAACCATACATGA, the sequence of N6-R is: TGACCCATTTCCCAACTTATAAGAG, the sequence of N6-P is AGGAGCCCATTTCG.
2. The use method of the H5N6 dual-fluorescence quantitative RT-PCR detection kit is characterized by comprising the following steps:
firstly, extracting sample RNA;
preparing a fluorescent quantitative PCR reaction system, wherein the system is as follows:
2×BIOGHSC Super MultiProbe Mix 10μl,BIOGHSC0.5. mu.l of Super Enzyme Mix, 0.5. mu.l of RT-PCR Enhancer, 0.5. mu.l of H5, 0.5. mu.l of N6 upstream primer (10. mu.M), 0.5. mu.l of H5, N6 downstream primer (10. mu.M), 0.5. mu.l of probe (20. mu.M), RNase-free ddH2O3.5. mu.l, template nucleic acid 4. mu.l;
the real-time fluorescent quantitative PCR reaction conditions are as follows: 20min at 42 ℃, 10min at 95 ℃ (15 s at 95 ℃, 35s at 55 ℃ and 45s at 72 ℃) for 40 cycles, and 10min at 72 ℃;
using linear plasmid containing H5 and N6 gene fragments diluted by 10 times of gradient as standard substance to carry out real-time fluorescence quantitative PCR, wherein the system is as follows:
2×BIOGHSC10 ul of Super Probe Master Mix, 0.5 ul of H5 and N6 upstream primer (10 uM), 0.5 ul of H5 and N6 downstream primer (10 uM), 2 ul of linear plasmid template, 0.5 ul of Probe, 0.4 ul of 50 XROX Reference dye, 0.2 ul of Taq enzyme protection solution, and ddH2And (3) O5.9 mul, wherein the reaction program is 95 ℃ for 10min, (95 ℃ for 15s, 55 ℃ for 35s, and 72 ℃ for 45s) for 40 cycles, the reaction program is 72 ℃ for 10min, a standard curve is established by taking the Log value of the copy number of the plasmid as the abscissa and the Ct value as the ordinate, and then the real-time fluorescence quantitative PCR detection result of the sample to be detected is compared with the standard curve to obtain the detection result.
CN202110524921.8A 2021-05-13 2021-05-13 H5N6 double-fluorescence quantitative RT-PCR detection kit Withdrawn CN113136460A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110524921.8A CN113136460A (en) 2021-05-13 2021-05-13 H5N6 double-fluorescence quantitative RT-PCR detection kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110524921.8A CN113136460A (en) 2021-05-13 2021-05-13 H5N6 double-fluorescence quantitative RT-PCR detection kit

Publications (1)

Publication Number Publication Date
CN113136460A true CN113136460A (en) 2021-07-20

Family

ID=76817727

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110524921.8A Withdrawn CN113136460A (en) 2021-05-13 2021-05-13 H5N6 double-fluorescence quantitative RT-PCR detection kit

Country Status (1)

Country Link
CN (1) CN113136460A (en)

Similar Documents

Publication Publication Date Title
Das et al. Development of an internal positive control for rapid diagnosis of avian influenza virus infections by real-time reverse transcription-PCR with lyophilized reagents
CN106435024B (en) Fluorescent quantitative PCR primer, probe, kit and detection method for detecting avian influenza virus subtype
Gall et al. Universal primer set for amplification and sequencing of HA0 cleavage sites of all influenza A viruses
CN108064315B (en) Method for detecting influenza
EP1761645A1 (en) Diagnostic primers and method for detecting avian influenza virus subtype h5 and h5n1
Tang et al. A multiplex RT-PCR assay for detection and differentiation of avian H3, H5, and H9 subtype influenza viruses and Newcastle disease viruses
CN106636472B (en) Complete set of reagent and method for detecting avian influenza virus and chicken parvovirus
US20170152577A1 (en) GeXP Rapid Detection Primer Set for Simultaneously Identifying Gene HA of Eight Different Human-Infected Subtypes of Avian Influenza Virus, Kit and Use Thereof
De Battisti et al. Rapid pathotyping of Newcastle Disease Virus by pyrosequencing
KR20230030639A (en) Methods for Detecting SARS-CoV-2, Influenza and RSV
KR20220044707A (en) Method for influenza a virus and influenza b virus detection
Lu et al. Development and evaluation of one-step TaqMan real-time reverse transcription-PCR assays targeting nucleoprotein, matrix, and hemagglutinin genes of equine influenza virus
CN103255236A (en) Double fluorescence quantitative reverse transcription-polymerase chain reaction (RT-PCR) detection kit for H7N9 avian influenza virus
CN110343784B (en) Composition and kit for quadruple influenza virus nucleic acid detection based on melting curve
CN101864494B (en) Constant-temperature amplification detection kit of A(H1N1) virus and detection method thereof
CN106636473B (en) Complete set of reagents and method for detecting H5 subtype avian influenza virus and chicken parvovirus
CN102534052B (en) Nucleic-acid sequence-based amplification (NASBA) method for detecting swine influenza virus (SIV)
KR102231338B1 (en) Primers and probes for detection of avian influenza, newcastle disease and avian infectious bronchitis viruses, and detecting method of avian influenza, newcastle disease and avian infectious bronchitis viruses using the same
CN111518954A (en) Primer group, kit and method for double nano PCR detection of H5 and N8 subtype avian influenza virus
CN108998575B (en) Establishment of double PCR detection method for chicken parvovirus and chicken newcastle disease virus
CN115323075B (en) RT-RAA primer probe group and kit for detecting infectious bronchitis viruses and genotyping and application of RT-RAA primer probe group and kit
WO2006132601A1 (en) Diagnostic primers and method for detecting avian influenza virus subtype h5 and h5n1
CN105950789A (en) Primer combination for identifying H5 subtype AIV (Avian Influenza Virus), N6 subtype AIV and AIV and application thereof
CN110669872A (en) Triple RT-PCR (reverse transcription-polymerase chain reaction) detection primer group, kit and method for H9 and H10 subtype avian influenza viruses
CN113136460A (en) H5N6 double-fluorescence quantitative RT-PCR detection kit

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20210720